<code id='BFF7ECCC0B'></code><style id='BFF7ECCC0B'></style>
    • <acronym id='BFF7ECCC0B'></acronym>
      <center id='BFF7ECCC0B'><center id='BFF7ECCC0B'><tfoot id='BFF7ECCC0B'></tfoot></center><abbr id='BFF7ECCC0B'><dir id='BFF7ECCC0B'><tfoot id='BFF7ECCC0B'></tfoot><noframes id='BFF7ECCC0B'>

    • <optgroup id='BFF7ECCC0B'><strike id='BFF7ECCC0B'><sup id='BFF7ECCC0B'></sup></strike><code id='BFF7ECCC0B'></code></optgroup>
        1. <b id='BFF7ECCC0B'><label id='BFF7ECCC0B'><select id='BFF7ECCC0B'><dt id='BFF7ECCC0B'><span id='BFF7ECCC0B'></span></dt></select></label></b><u id='BFF7ECCC0B'></u>
          <i id='BFF7ECCC0B'><strike id='BFF7ECCC0B'><tt id='BFF7ECCC0B'><pre id='BFF7ECCC0B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:1851
          Grail

          Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

          The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

          advertisement

          All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          Study suggests Covid rebound is far more common with Paxlovid than without
          Study suggests Covid rebound is far more common with Paxlovid than without

          AdobeAsmallandpreliminarystudypublishedMondayseemstoindicatethatpatientsreceivingthedrugPaxlovidaref

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Couple fighting to bring baby home from Mexico are finally reunited

          3:22LauraandSamKaitztalkedtoABC's"GoodMorningAmerica"onJuly17,20223,aboutthechallengestheyfacedusing